Prometic is a biopharmaceutical corporation with two drug discovery platforms focused on unmet medical needs. The first platform is based on two receptors involved in healing, the second leverages Prometic bioseparation's expertise for the development of plasma derived therapeutics.
Prometic has developed a deep pipeline of late stage clinically active, well tolerated and safe orphan drug candidates targeting unmet medical needs in the field of fibrosis and rare diseases using both its small molecule and plasma derived drug discovery platforms.
Why Invest? Prometic has a deep pipeline of drug candidates that are safe and well tolerated with clinically proven activity targeting significant unmet medical needs. Prometic's proprietary drug development platforms enjoy strong IP protection and can generate multiple products.